{"id":7070,"date":"2025-05-22T13:44:09","date_gmt":"2025-05-22T10:44:09","guid":{"rendered":"https:\/\/jordan-cardiac.org\/?p=7070"},"modified":"2025-05-22T13:44:09","modified_gmt":"2025-05-22T10:44:09","slug":"risk-scores-for-asymptomatic-individuals-tools-for-predicting-cardiovascular-risk","status":"publish","type":"post","link":"https:\/\/jordan-cardiac.org\/en\/risk-scores-for-asymptomatic-individuals-tools-for-predicting-cardiovascular-risk\/","title":{"rendered":"Risk Scores for Asymptomatic Individuals & Tools for Predicting Cardiovascular Risk"},"content":{"rendered":"
Risk Scores for Asymptomatic Individuals & Tools for Predicting Cardiovascular Risk<\/div>\n
<\/div>\n
These tools are designed to estimate the future risk of cardiovascular events\u2014such as myocardial infarction or stroke\u2014over a specific period (usually 10 years or over a lifetime). They are preventive in nature and do not require symptoms. Based on clinical and\/or imaging markers, they support decision-making in lifestyle modifications and primary prevention strategies (e.g., statins).<\/div>\n
<\/div>\n
Below is a summary of the most relevant and widely used risk assessment tools in asymptomatic populations:<\/div>\n
<\/div>\n
1. SCORE2 \/ SCORE2-OP (Europe \u2013 ESC)<\/div>\n
\u2022 Target: Adults aged 40\u201369 (SCORE2), and \u226570 (SCORE2-OP)<\/span><\/div>\n
\u2022 Purpose: 10-year risk of first fatal and non-fatal CVD event<\/span><\/div>\n
\u2022 Ideal for: European general population<\/span><\/div>\n
\u2022 Variables: Age, sex, systolic BP, cholesterol, smoking, diabetes<\/span><\/div>\n
<\/div>\n
2. ASCVD Risk Estimator Plus (USA \u2013 ACC\/AHA)<\/div>\n
\u2022 Target: Adults aged 40\u201379 without known ASCVD<\/span><\/div>\n
\u2022 Purpose: 10-year and lifetime ASCVD risk<\/span><\/div>\n
\u2022 Variables: Race, cholesterol, BP, smoking, diabetes, medications<\/span><\/div>\n
\u2022 Features: Includes therapy adjustment (e.g., statins, aspirin)<\/span><\/div>\n
<\/div>\n
3. QRISK3 (UK \u2013 NHS)<\/div>\n
\u2022 Target: Adults aged 25\u201384 without CVD<\/span><\/div>\n
\u2022 Purpose: 10-year risk of MI or stroke<\/span><\/div>\n
\u2022 Variables: Comorbidities, ethnicity, medications, social factors<\/span><\/div>\n
\u2022 Tailored for: UK population and NHS use<\/span><\/div>\n
<\/div>\n
4. Framingham Risk Score (USA \u2013 NHLBI)<\/div>\n
\u2022 Target: Adults aged 30\u201374 without prior CVD<\/span><\/div>\n
\u2022 Purpose: 10-year CHD\/CVD risk estimate<\/span><\/div>\n
\u2022 Notes: Historic model, may overestimate risk in modern settings<\/span><\/div>\n
<\/div>\n
5. Reynolds Risk Score (USA \u2013 Harvard)<\/div>\n
\u2022 Target: Men \u226550, Women \u226545, healthy individuals<\/span><\/div>\n
\u2022 Purpose: 10-year CVD risk<\/span><\/div>\n
\u2022 Includes: hs-CRP and family history in addition to classic factors<\/span><\/div>\n
\u2022 Best for: Patients with suspected inflammatory risk profile<\/span><\/div>\n
<\/div>\n
6. MESA Risk Score (USA \u2013 MESA Study)<\/div>\n
\u2022 Target: Intermediate-risk, asymptomatic adults<\/span><\/div>\n
\u2022 Purpose: 10-year CHD risk<\/span><\/div>\n
\u2022 Variables: Clinical + CAC score from cardiac CT<\/span><\/div>\n
\u2022 Use: Excellent for reclassification and personalized therapy<\/span><\/div>\n
<\/div>\n
7. CAC Score (Agatston Score)<\/div>\n
\u2022 Type: Imaging-only via coronary CT<\/span><\/div>\n
\u2022 Best for: Intermediate-risk patients without symptoms<\/span><\/div>\n
\u2022 Interpretation:<\/span><\/div>\n
\u2022 CAC = 0: Very low risk<\/span><\/div>\n
\u2022 CAC 1\u2013100: Mild\/moderate<\/span><\/div>\n
\u2022 CAC >100 or >75th percentile: High risk<\/span><\/div>\n
\u2022 Use: Supports statin decision-making<\/span><\/div>\n
\u2022 Endorsed: 2018 AHA\/ACC Guidelines and 2021 AHA Scientific Statement<\/span><\/div>\n
<\/div>\n
Direct Access Links:<\/div>\n
1. SCORE2 Risk Calculator \u2013 ESC:<\/span><\/div>\n
https:\/\/www.escardio.org\/Education\/ESC-Scientific-Document-Library\/SCORE2-new-CVD-risk-assessment-in-Europe<\/a><\/div>\n
2. ASCVD Risk Estimator Plus:<\/span><\/div>\n
https:\/\/tools.acc.org\/ASCVD-Risk-Estimator-Plus<\/a><\/div>\n
3. QRISK3 Calculator:<\/span><\/div>\n
https:\/\/www.qrisk.org\/three\/<\/a><\/div>\n
4. Framingham Risk Score Tool \u2013 MDCalc:<\/span><\/div>\n
https:\/\/www.mdcalc.com\/calc\/61\/framingham-risk-score-hard-coronary-heart-disease<\/a><\/div>\n
5. Reynolds Risk Score:<\/span><\/div>\n
https:\/\/www.reynoldsriskscore.org\/<\/a><\/div>\n
6. MESA Risk Score Calculator:<\/span><\/div>\n
https:\/\/www.mesanhlbi.org\/MESACHDRisk\/MesaRiskScore\/RiskScore.aspx<\/a><\/div>\n
7. 2021 AHA Scientific Statement on CAC:<\/span><\/div>\n
https:\/\/www.ahajournals.org\/doi\/10.1161\/CIR.0000000000000946<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"

Risk Scores for Asymptomatic Individuals & Tools for Predicting Cardiovascular Risk These tools are designed to estimate the future risk of cardiovascular events\u2014such as myocardial infarction or stroke\u2014over a specific period (usually 10 years or over a lifetime). They are preventive in nature and do not require symptoms. Based on clinical and\/or imaging markers, they […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-7070","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/7070","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/comments?post=7070"}],"version-history":[{"count":1,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/7070\/revisions"}],"predecessor-version":[{"id":7078,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/7070\/revisions\/7078"}],"wp:attachment":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/media?parent=7070"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/categories?post=7070"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/tags?post=7070"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}